Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
Clinical trial NCT05735834 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05735834
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2029-05-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.